Colton Foundation Funds $15 Million Autoimmune Research
A new three-year international consortium connects top universities to advance autoimmune disease treatment and research.
Updated on Oct. 29, 2026 in Allergies
Live Poll
Does cross-disciplinary collaboration effectively improve long-term outcomes for patients with chronic autoimmune diseases?
The Colton Foundation has launched a $15 million, three-year research initiative to combat autoimmune diseases. This international consortium integrates the efforts of Tel Aviv University, New York University, and Yale University.
Why it matters
The initiative aims to understand disease triggers, develop treatments with fewer side effects, and reduce the overall prevalence of these conditions. By integrating multidisciplinary experts, the project seeks to improve clinical outcomes for patients dealing with complex comorbidities.
Autoimmune diseases impact approximately 5% to 8% of the global population, covering a spectrum of 100 different illnesses. The new $15 million funding cycle supports a three-year effort across three major partner universities.
The players
Colton Foundation
A philanthropic organization that provides financial support for medical research and scientific initiatives.
Tel Aviv University
A major public research university in Israel that serves as the host for the Colton Center for Autoimmunity.
New York University
A prominent private research university in the United States participating as a key member of the new consortium.
Yale University
A prestigious Ivy League research institution in the United States contributing expertise to the autoimmune research network.
The details
The Colton Center for Autoimmunity operates in collaboration with the Clalit health fund to coordinate care across multiple medical disciplines. Multidisciplinary teams, including mathematicians, physicists, and engineers, utilize disease committees to allow patients to consult with several specialists at once.
Timeline
The research consortium project spans a three-year duration.
The Big Picture
The Colton Center for Autoimmunity represents a shift toward integrated, cross-disciplinary health research programs. This new investment extends the center's existing framework by scaling collaborative faculty recruitment and multi-institutional studies.
The implementation of multidisciplinary autoimmune committees allows patients to address complex comorbidities with a coordinated team of specialists. This integrated care model aims to streamline consultations and potentially reduce the side effects of current treatment plans.
The takeaway
Patients managing autoimmune conditions may benefit from the move toward specialized committee-based care that looks at the body as a whole. Future developments from this consortium may eventually lead to more targeted therapies that minimize adverse drug reactions.
Further reading
For more information on the latest research in the field, visit Allergies.
Source note: This article includes information reported by The Jerusalem Post.
Live Poll
Does cross-disciplinary collaboration effectively improve long-term outcomes for patients with chronic autoimmune diseases?
